BR112012023264A8 - método para alterar a composição dos ácidos graxos da membrana cerebral, método para aperfeiçoar o desempenho cognitivo em um indivíduo humano e uso de uma composição - Google Patents

método para alterar a composição dos ácidos graxos da membrana cerebral, método para aperfeiçoar o desempenho cognitivo em um indivíduo humano e uso de uma composição

Info

Publication number
BR112012023264A8
BR112012023264A8 BR112012023264A BR112012023264A BR112012023264A8 BR 112012023264 A8 BR112012023264 A8 BR 112012023264A8 BR 112012023264 A BR112012023264 A BR 112012023264A BR 112012023264 A BR112012023264 A BR 112012023264A BR 112012023264 A8 BR112012023264 A8 BR 112012023264A8
Authority
BR
Brazil
Prior art keywords
composition
fatty acid
human individual
cognitive performance
brain membrane
Prior art date
Application number
BR112012023264A
Other languages
English (en)
Other versions
BR112012023264A2 (pt
Inventor
Annemiek Lidewij Schipper
Eline Marleen Van Der Beek
Gelske Speelmans
Marieke Abrahamse Berkeveld
Original Assignee
Nutricia Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43487597&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112012023264(A8) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nutricia Nv filed Critical Nutricia Nv
Publication of BR112012023264A2 publication Critical patent/BR112012023264A2/pt
Publication of BR112012023264A8 publication Critical patent/BR112012023264A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A23D7/01—Other fatty acid esters, e.g. phosphatides
    • A23D7/011—Compositions other than spreads
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A23D7/01—Other fatty acid esters, e.g. phosphatides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
    • A23D9/007—Other edible oils or fats, e.g. shortenings, cooking oils characterised by ingredients other than fatty acid triglycerides
    • A23D9/013—Other fatty acid esters, e.g. phosphatides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
    • A23D9/02—Other edible oils or fats, e.g. shortenings, cooking oils characterised by the production or working-up
    • A23D9/04—Working-up
    • A23D9/05—Forming free-flowing pieces
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J7/00—Phosphatide compositions for foodstuffs, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/30—Encapsulation of particles, e.g. foodstuff additives
    • A23P10/35—Encapsulation of particles, e.g. foodstuff additives with oils, lipids, monoglycerides or diglycerides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Pediatric Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Addiction (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
BR112012023264A 2010-03-17 2011-03-17 método para alterar a composição dos ácidos graxos da membrana cerebral, método para aperfeiçoar o desempenho cognitivo em um indivíduo humano e uso de uma composição BR112012023264A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/NL2010/050142 WO2011115476A1 (en) 2010-03-17 2010-03-17 Infant nutrition for improving fatty acid composition of brain membranes later in life
PCT/NL2011/050188 WO2011115491A1 (en) 2010-03-17 2011-03-17 Infant nutrition for improving fatty acid composition of brain membranes

Publications (2)

Publication Number Publication Date
BR112012023264A2 BR112012023264A2 (pt) 2015-09-15
BR112012023264A8 true BR112012023264A8 (pt) 2015-10-20

Family

ID=43487597

Family Applications (2)

Application Number Title Priority Date Filing Date
BR112012023267A BR112012023267A2 (pt) 2010-03-17 2011-03-17 Método para alterar a composição dos ácidos graxos da membrana cerebral, método para aperfeiçoar o desempenho cognitivo em um indivíduo humano e uso de uma composição
BR112012023264A BR112012023264A8 (pt) 2010-03-17 2011-03-17 método para alterar a composição dos ácidos graxos da membrana cerebral, método para aperfeiçoar o desempenho cognitivo em um indivíduo humano e uso de uma composição

Family Applications Before (1)

Application Number Title Priority Date Filing Date
BR112012023267A BR112012023267A2 (pt) 2010-03-17 2011-03-17 Método para alterar a composição dos ácidos graxos da membrana cerebral, método para aperfeiçoar o desempenho cognitivo em um indivíduo humano e uso de uma composição

Country Status (9)

Country Link
US (4) US9474764B2 (pt)
EP (4) EP2547216B1 (pt)
CN (3) CN104351796A (pt)
BR (2) BR112012023267A2 (pt)
ES (2) ES2642635T3 (pt)
MY (1) MY166016A (pt)
PL (2) PL2547217T3 (pt)
RU (4) RU2692920C2 (pt)
WO (3) WO2011115476A1 (pt)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2341784T1 (sl) * 2008-09-02 2013-01-31 N.V. Nutricia Prehrambeni sestavki s prevlečenimi lipidnimi globulami
WO2011115476A1 (en) 2010-03-17 2011-09-22 N.V. Nutricia Infant nutrition for improving fatty acid composition of brain membranes later in life
JP2015501426A (ja) * 2011-10-21 2015-01-15 オムセラ・ファーマシューティカルズ・インコーポレイテッド 注意欠陥多動障害を処置するまたは予防する方法および組成物
SE536599C3 (sv) 2012-04-10 2017-01-10 Hero Ag Näringssammansättning med lågt kalori- och lågt proteininnehåll
WO2014058301A1 (en) * 2012-10-12 2014-04-17 N.V. Nutricia Infant nutrition with lipid globules to increase energy expenditure and metabolic flexibility later in life
US9661874B2 (en) 2013-03-11 2017-05-30 Mead Johnson Nutrition Company Nutritional compositions containing structured fat globules and uses thereof
US10455854B2 (en) 2013-03-11 2019-10-29 Mead Johnson Nutrition Company Nutritional compositions containing structured fat globules and uses thereof
US9980506B2 (en) 2013-03-11 2018-05-29 Mead Johnson Nutrition Co. Nutritional compositions containing structured fat globules and uses thereof
US9609888B2 (en) * 2013-07-31 2017-04-04 Mead Johnson Nutrition Company Nutritional compositions containing synergistic combination and uses thereof
US10709770B2 (en) 2013-07-31 2020-07-14 Mead Johnson Nutrition Company Nutritional compositions containing a prebiotic and lactoferrin and uses thereof
EP3091973B1 (en) 2013-11-01 2018-08-15 N.V. Nutricia Lipid composition for improving body composition during catch-up growth
CN105792675A (zh) * 2013-12-12 2016-07-20 雀巢产品技术援助有限公司 用于促进男性和女性婴儿及儿童认知功能的健康建立的包含多不饱和脂肪酸类(pufa)的合成乳组合物
CN107072277A (zh) * 2014-08-15 2017-08-18 N·V·努特里奇亚 用于改善行为的脂质组合物
FR3026918B1 (fr) * 2014-10-13 2018-02-23 Even Sante Industrie Procede d'obtention d'un lait infantile pret a l'emploi et de longue conservation
EP3223825A1 (en) * 2014-11-26 2017-10-04 Abbott Laboratories Infant formula comprising human milk oligosaccharides, polyunsaturated fatty acids, nucleotides, and lutein
CN107771035A (zh) * 2015-04-10 2018-03-06 N·V·努特里奇亚 用于脂质消化的具有包含乳磷脂包被的植物脂肪的大脂质小球的营养物
US10617701B2 (en) 2015-07-10 2020-04-14 Mead Johnson Nutrition Company Nutritional compositions containing phosphatidylethanolamine, sphingomyelin and docosahexaenoic acid
US10582714B2 (en) 2015-07-10 2020-03-10 Mead Johnson Nutrition Company Nutritional compositions and methods for promoting cognitive development
HUE054161T2 (hu) * 2015-08-17 2021-08-30 St Ip Holding Ag Megnövelt stabilitású és javított abszorpciójú honokiol és magnolol készítmények és ezek alkalmazása
BR112018007095B1 (pt) 2015-10-15 2022-07-05 N.V. Nutricia Composição nutricional
US11129404B2 (en) 2015-12-28 2021-09-28 Abbott Laboratories Nutritional compositions comprising hydrolyzed protein and a modified fat system and uses thereof
WO2017183956A1 (en) * 2016-04-18 2017-10-26 N.V. Nutricia Linoleic acid and alpha-linolenic acid for use for reducing early-life stress induced cognitive decline
RU2741495C2 (ru) * 2016-04-18 2021-01-26 Н.В. Нютрисиа Линолевая кислота или альфа-линоленовая кислота для применения с целью уменьшения когнитивных нарушений/снижения нейрогенеза, индуцированных стрессом в раннем периоде жизни
CA3038720A1 (en) 2016-11-04 2018-07-12 Regeneron Pharmaceuticals, Inc. Non-human animals having an engineered immunoglobulin lambda light chain locus
EP3550985B1 (en) 2016-12-09 2021-01-06 N.V. Nutricia Nutritional composition for improving cell membranes
EP3599896A1 (en) * 2017-03-29 2020-02-05 N.V. Nutricia Infant formula for improved eating behaviour
WO2019193037A1 (en) * 2018-04-03 2019-10-10 N.V. Nutricia Nutritional composition for use in the prevention of dry skin
AU2021212325A1 (en) * 2020-01-31 2022-07-28 N.V. Nutricia Nutritional composition for use in gut maturation
WO2021200698A1 (ja) * 2020-04-01 2021-10-07 サントリーホールディングス株式会社 友好性及び／又は共感力改善用組成物
WO2023208925A1 (en) 2022-04-25 2023-11-02 N.V. Nutricia Nutritional composition for use in preventing programmed obesity in female infants
WO2023232882A1 (en) 2022-05-31 2023-12-07 N.V. Nutricia Infant formula for improving cognitive development
WO2024121222A1 (en) * 2022-12-06 2024-06-13 N.V. Nutricia Infant formula for improving cognitive development

Family Cites Families (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1084006A1 (ru) 1981-11-09 1984-04-07 Казахский Филиал Института Питания Амн Ссср Способ приготовлени пищевой эмульсии
NL8800629A (nl) 1988-03-15 1989-10-02 Ver Coop Melkind Gesproeidroogd melkpoederprodukt en werkwijze voor de bereiding daarvan.
ES2033193B1 (es) 1990-10-30 1994-01-16 Ganadera Union Ind Agro Mezcla grasa para nutricion infantil y de adultos.
IL119982A (en) 1997-01-09 2000-07-26 Shapira Niva Bottle for infant feeding
AU745551B2 (en) 1997-03-27 2002-03-21 Bristol-Myers Squibb Company Use of docosahexanoic acid and arachidonic acid enhancing the growth of preterm infants
JP2001158736A (ja) 1999-11-30 2001-06-12 Snow Brand Milk Prod Co Ltd 骨関節疾患の予防及び改善剤
US6495599B2 (en) * 2000-04-13 2002-12-17 Abbott Laboratories Infant formulas containing long-chain polyunsaturated fatty acids and uses therof
US7090862B2 (en) 2001-03-30 2006-08-15 Abbott Laboratories Method of improving the antioxidant status of an infant
US6620427B2 (en) 2001-04-24 2003-09-16 Abbott Laboratories Method for improving bone mineralization
US20050019372A1 (en) 2001-07-10 2005-01-27 Barbara E Corkey Modified-fat nutritional products useful preventing or treating obesity
US6902739B2 (en) 2001-07-23 2005-06-07 Nutracea Methods for treating joint inflammation, pain, and loss of mobility
JP4446962B2 (ja) 2003-07-16 2010-04-07 出光興産株式会社 樹脂材料への超音波振動付与装置、この超音波振動付与装置を用いた樹脂材料の溶融成形方法及び樹脂組成物
US20050037089A1 (en) 2003-08-06 2005-02-17 Jobbins Jill Marie Method for promoting bone growth
IL158555A0 (en) 2003-10-22 2004-05-12 Enzymotec Ltd Human breast milk lipid mimetic as dietary supplement
IL158554A0 (en) 2003-10-22 2004-05-12 Enzymotec Ltd Mimetic lipids as dietary supplements
AU2004292416B2 (en) 2003-11-20 2010-01-28 Alteragon Pty Ltd Method of decreasing fat deposits and body weight in mammals and birds
US9040075B2 (en) 2003-12-19 2015-05-26 Abbott Laboratories Method of increasing lean body mass and reducing body fat mass in infants
US8252769B2 (en) * 2004-06-22 2012-08-28 N. V. Nutricia Intestinal barrier integrity
EP1811867A2 (en) 2004-11-12 2007-08-01 N.V. Nutricia Food composition comprising a protein- and a lipid fraction for rapidly attenuating inflammatory responses
DE602006006654D1 (de) 2005-03-08 2009-06-18 Nestec Sa Verfahren zur herstellung von nährmittelzusammensetzungen
US20060210697A1 (en) 2005-03-18 2006-09-21 Mower Thomas E Infant formula composition
EP2382872A1 (en) 2005-04-28 2011-11-02 Enzymotec Ltd. Polar lipid mixtures, their preparation and uses
TWI282268B (en) 2005-09-15 2007-06-11 Univ Chung Shan Medical Medical image system and method for measuring vertebral axial rotation
US7311676B2 (en) 2005-09-23 2007-12-25 Park Sangdo Portable non-invasive device for measuring the hardness of muscle or muscle compartment
RU2445360C2 (ru) 2005-10-05 2012-03-20 Нестек С.А. Композиция для компенсации задержки роста
WO2008054192A1 (en) 2006-11-02 2008-05-08 N.V. Nutricia Use of nutritional compositions for preventing disorders
RU2417712C2 (ru) 2005-12-23 2011-05-10 Н.В. Нютрисиа Питательная композиция для младенцев, предназначенная для предупреждения ожирения
ES2366034T3 (es) * 2005-12-23 2011-10-14 N.V. Nutricia Composición que comprende ácidos grasos poliinsaturados, proteínas, manganeso y/o molibdeno y nucleósidos/nucleótidos para el tratamiento de la demencia.
KR100598607B1 (ko) 2006-02-24 2006-07-07 주식회사 일신웰스 유지 조성물 및 이의 제조방법
US20080003330A1 (en) 2006-06-30 2008-01-03 Ricardo Rueda Infant formulas for early brain development
WO2008003330A1 (en) * 2006-07-07 2008-01-10 Danmarks Tekniske Universitet (Technical University Of Denmark) Variable trailing edge section geometry for wind turbine blade
EP1932437A1 (en) 2006-12-15 2008-06-18 Nestec S.A. Infant formula
WO2008081934A1 (ja) 2006-12-28 2008-07-10 Meiji Dairies Corporation 乳由来リン脂質を含有する乳幼児脳発達促進剤及びそれを含有する食品組成物
WO2009051502A1 (en) 2007-10-19 2009-04-23 Steven Charles Hodgkinson Methods of maintaining or increasing growth or cognitive development
ES2660416T3 (es) * 2007-11-01 2018-03-22 Enzymotec Ltd. Mezcla de lípidos para la nutrición de bebés
CN101939010A (zh) 2007-11-19 2011-01-05 雪印乳业株式会社 感觉改善剂
FR2930406B1 (fr) 2008-04-29 2011-04-15 Groupe Lactalis Aliment infantile a base de matiere grasse d'origine laitiere
RU2492706C2 (ru) 2008-06-16 2013-09-20 Н.В. Нютрисиа Композиция с жировым градиентом
SI2341784T1 (sl) 2008-09-02 2013-01-31 N.V. Nutricia Prehrambeni sestavki s prevlečenimi lipidnimi globulami
WO2010068086A1 (en) 2008-12-11 2010-06-17 N.V. Nutricia Nutritional compositions with large lipid globule size
WO2010070613A2 (en) 2008-12-18 2010-06-24 University College London Baby feeding formula and system
WO2010134800A1 (en) 2009-05-19 2010-11-25 N.V. Nutricia Human milk fortifier with high protein and long chain poly unsaturated fatty acids for improving body adipose tissue distribution
WO2011071367A1 (en) 2009-12-11 2011-06-16 N.V. Nutricia Metabolic imprinting effects of structured lipids
WO2011108918A1 (en) 2010-03-04 2011-09-09 N.V. Nutricia Modulation of post-prandial fat absorption
WO2011115476A1 (en) 2010-03-17 2011-09-22 N.V. Nutricia Infant nutrition for improving fatty acid composition of brain membranes later in life
WO2012173467A1 (en) 2011-06-16 2012-12-20 N.V. Nutricia Metabolic imprinting effects of specifically designed lipid component
WO2013036102A1 (en) 2011-09-08 2013-03-14 N.V. Nutricia Use of infant formula with cholesterol
WO2013036104A1 (en) 2011-09-08 2013-03-14 N.V. Nutricia Infant nutrition for regulating food intake later in life
WO2013036103A1 (en) 2011-09-08 2013-03-14 N.V. Nutricia Use of infant formula with large lipid globules
EP2583562A1 (en) 2011-10-21 2013-04-24 Nestec S.A. Use of whey protein micelles for infants at risk of obesity or diabetes
SE536599C3 (sv) 2012-04-10 2017-01-10 Hero Ag Näringssammansättning med lågt kalori- och lågt proteininnehåll
WO2013191533A1 (en) 2012-06-18 2013-12-27 N.V. Nutricia Metabolic imprinting effects of nutrition with large lipid globules comprising milk fat and vegetable fat
EP3091973B1 (en) 2013-11-01 2018-08-15 N.V. Nutricia Lipid composition for improving body composition during catch-up growth
EP3082463B1 (en) 2013-11-29 2019-05-01 Nestec S.A. Use of nutritional compositions having a low protein amount
EP3082473A2 (en) 2013-12-19 2016-10-26 Nestec S.A. Nutritional composition to reduce metabolic stress in infants

Also Published As

Publication number Publication date
RU2692920C2 (ru) 2019-06-28
RU2559113C2 (ru) 2015-08-10
WO2011115476A1 (en) 2011-09-22
CN102892300A (zh) 2013-01-23
EP2547217B1 (en) 2017-07-19
RU2015127482A (ru) 2018-12-24
EP3332649A1 (en) 2018-06-13
CN102905542B (zh) 2014-10-22
WO2011115491A1 (en) 2011-09-22
US20150306117A1 (en) 2015-10-29
RU2012144021A (ru) 2014-04-27
ES2656154T3 (es) 2018-02-23
US10548869B2 (en) 2020-02-04
BR112012023264A2 (pt) 2015-09-15
EP2547216A1 (en) 2013-01-23
RU2015127482A3 (pt) 2018-12-24
MY166016A (en) 2018-05-21
WO2011115490A1 (en) 2011-09-22
RU2012144016A (ru) 2014-04-27
CN102905542A (zh) 2013-01-30
CN102892300B (zh) 2016-03-30
CN104351796A (zh) 2015-02-18
US20130071446A1 (en) 2013-03-21
RU2015130598A (ru) 2018-12-24
EP2547217A1 (en) 2013-01-23
RU2560861C2 (ru) 2015-08-20
PL2547216T3 (pl) 2018-04-30
PL2547217T3 (pl) 2018-01-31
BR112012023267A2 (pt) 2017-10-03
EP3332649B1 (en) 2024-04-24
US9474764B2 (en) 2016-10-25
US20130096087A1 (en) 2013-04-18
EP3272221A1 (en) 2018-01-24
RU2692627C2 (ru) 2019-06-25
EP2547216B1 (en) 2017-11-15
US20170151203A1 (en) 2017-06-01
ES2642635T3 (es) 2017-11-17
RU2015130598A3 (pt) 2018-12-24

Similar Documents

Publication Publication Date Title
BR112012023264A8 (pt) método para alterar a composição dos ácidos graxos da membrana cerebral, método para aperfeiçoar o desempenho cognitivo em um indivíduo humano e uso de uma composição
CO6940374A2 (es) Composiciones, usos y métodos para tratamiento de trastornos y enfermedades metabólicas
CO6910173A2 (es) Aplicacion y metodo para entrenamiento de habilidades quirurgicas
CL2014001628A1 (es) Metodos para purificar glicosidos de ateviol; composiciones y usos de los mismos
BR112012029746A2 (pt) composição para tratamento da pele, método para fornecer um efeito microbicida para pele e uso de uma combinação
BRPI1013640A2 (pt) composicao farmaceutica, metodos para o tratamento e usos dos mesmos
BR112012032172A2 (pt) método para produzir um álcool e composição
EP2833798A4 (en) MULTIPLE SUTURE-FREE ANCHORING FOR ATTACHING FABRIC TO BONE AND METHOD THEREOF
BR112013018877A2 (pt) composições farmacêuticas que compreendem anticorpos humanos para pcsk9
BR112014027633A2 (pt) composição de cuidados pessoais, métodos para fornecer uma sensação refrescante e utilização de um copolímero
BR112013009483A2 (pt) "estrutura substancialmente desprovida de celulose para utilização em um artigo absorvente, artigo absorvente e método de fabricação de uma estrutura abosrvente"
BR112013009142A2 (pt) "composição modeladora de fibra queratinosa, kit modelador de fibra queratinosa e métod para tratamento de uma fibra queratinosa"
BR112012017831A8 (pt) micro-organismos produtores de ácido eicosapentaenoico, composições de ácido graxo e métodos de fabricação e uso dos mesmos
BR112013011730A2 (pt) composição de oligossacarídeos para tratar doenças da pele
BR112013021274A2 (pt) composição cosmética botânica bioativa, formulação cosmética botânica bioativa, e método para preparar uma composição cosmética botânica bioativa
BRPI1006024B8 (pt) composição cosmética emulsificada para cuidado da pele
BR112014012753A8 (pt) composição para pele e método de hidratação da pele
BR112012028592A2 (pt) método para fabricação de uma composição de glicosaminoglicano, composição de glicosaminoglicano, seus usos e preparação adequada para aplicação à pele ou membrana mucosa
BRPI0912134A2 (pt) preparação externa para pele
FR2966718B1 (fr) Implant de laminoplastie, notamment cervicale
CO6950485A2 (es) Composiciones perfumantes y usos de las mismas
CO6950484A2 (es) Composiciones perfumantes y usos de las mismas
BR112012027145A2 (pt) emulsão, composição de uso final e método para tratar uma condição cutânea
BR112015002681A2 (pt) método para tratar um paciente e kit
BR112013014103A2 (pt) método para produzir um l-aminoácido

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A61K 31/202 (2006.01), A23D 7/01 (2006.01), A23D 9

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B06T Formal requirements before examination [chapter 6.20 patent gazette]
B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B11N Dismissal: publication cancelled [chapter 11.14 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 11.5 NA RPI NO 2526 DE 04/06/2019 POR TER SIDO INDEVIDA.

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]